Learn

Diabetes Research Review Issue 142 with commentary by Professor Mathis Grossmann.  

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Diabetes. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au 

Details

In this edition we feature:

• Semaglutide and automated insulin delivery in type 1 diabetes
• Vitamin D supplementation and incident type 2 diabetes
• Semaglutide in MASH
• Tirzepatide and muscle composition changes in type 2 diabetes
• IcoSema vs. icodec or basal-bolus insulin in type 2 diabetes
• Altered brain function and structure in youth-onset type 2 diabetes
• Finerenone and empagliflozin in chronic kidney disease and type 2 diabetes
• High-dose semaglutide in type 2 diabetes and overweight/obesity
• Long-term effects of lifestyle and metformin interventions on type 2 diabetes incidence

To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.